SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD), a global leader in cloud-connected respiratory care devices, today announced key upgrades to its Astral life support ventilators, including ...

ResMed, a leader in digital health with over 22.5 million cloud-connected devices sold, excels in treating respiratory disorders like sleep apnea, impacting over 1 billion globally. Recent data from ...

Propeller will continue to operate as a standalone business within ResMed’s Respiratory Care portfolio. There won’t be any immediate changes to locations, business processes or management. Propeller ...

San Diego-based ResMed has received a $32 million contract with the U.S. Department of Health and Human Services to produce 2,550 ventilators to meet patient needs across the United States from the ...

LYON, France--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD), a world-leading digital health company, today launched cloud-based remote monitoring software for ventilators and Lumis bilevel devices ...